Voices
Amol Akhade: What are Key Concerned Raised by FDA Against SERENA-6 Trial
Amol Akhade/LinkedIn

Amol Akhade: What are Key Concerned Raised by FDA Against SERENA-6 Trial

Amol Akhade, Senior Consultant Medical Oncologist and Hemato-Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post on LinkedIn:

“What are key concerned raised by FDA against SERENA -6 trial.

Check out below.

It summarizes all of FDA concerns.

Do u agree?”

Amol Akhade: What are Key Concerned Raised by FDA Against SERENA-6 Trial

More posts about SERENA-6 trial.

Amol Akhade cancer FDA OncoDaily Oncology serena 6 trial